PROVANT® wound-closure system accelerates closure of pressure wounds in a randomized, double-blind, placebo-controlled trial

Annals of the New York Academy of Sciences

Volumn 961, Issue , 2002, Pages 356-359

  Ritz, M C ^a   Gallegos, R ^b   Canham, M B ^a   Eskalai, M ^c   George, F R ^a  

^a Regenesis Biomedical Inc   (United States)

^b John C Lincoln Hospital   (United States)

^c ARIZONA STATE UNIVERSITY   (United States)

Author keywords

Cell proliferation; Pressure ulcer; Pressure wound; PROVANT

Indexed keywords

PLACEBO;

CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECUBITUS; DEVICE; DOUBLE BLIND PROCEDURE; HUMAN; RANDOMIZED CONTROLLED TRIAL; AGED; ARTICLE; BIOPHYSICS; CELL DIVISION; CYTOLOGY; EPITHELIUM CELL; FIBROBLAST; MIDDLE AGED; RADIATION EXPOSURE; RADIOFREQUENCY RADIATION; TIME; ULCER; WOUND HEALING;

AGED; BIOPHYSICS; CELL DIVISION; DOUBLE-BLIND METHOD; EPITHELIAL CELLS; FIBROBLASTS; HUMANS; MIDDLE AGED; PLACEBOS; RADIO WAVES; TIME FACTORS; ULCER; WOUND HEALING;

EID: 0035983145     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2002.tb03123.x     Document Type: Conference Paper

References (5)

1. Epidemiology of pressure sores in different populations
2. Pressure ulcers: Prevention and management
3. Medicare reimbursement for pressure ulcers: Strategy for change
4. Cell proliferation induction (CPI®): Dose- and time-dependent effects on fibroblast proliferation in vitro
5. Cell proliferation induction (cpi): In vitro evidence for enhanced diffusible growth factor release related to accelerated wound healing